29/10/2016 - A group of researchers lead by Diether Lambrechts (VIB-KU Leuven) explored the mechanisms that cause increased levels of methylation in tumor genes — information that is vital to the adaptation of therapies to fight different types of tumors.
17/08/2016 - The lack of oxygen in tumor cells changes the cells’ gene expression, thereby contributing to the growth of cancer. This is the main conclusion of a research project led by professor Diether Lambrechts and Dr. Bernard Thienpont (VIB-KU Leuven).
13/07/2015 - “These results will be the foundation of many future studies on the genetic aberrations controlling cancer development” - Diether Lambrechts, VIB-KU Leuven
09/12/2013 - ERC-grants grants for three VIB scientists: boost for innovative research
06/12/2013 - Diether Lambrechts (VIB/KU Leuven) and the biotech company, Biocartis, are working together on a new diagnostic test for certain types of cancer.
27/03/2013 - An international consortium has identified more than 80 regions in our DNA that increase a person’s risk of developing breast, prostate and ovarian cancer.
21/05/2012 - VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that can predict which patients will benefit from treatment with bevacizumab (Avastin).
19/12/2011 - VIB scientists describe in Nature Biotechnology a method that reduces the error rate in detecting genomic variants by short-read sequencing technologies Complete Genomics and Illumina
01/10/2010 - VIB has licensed the RTG v2 Software from Real Time Genomics, for variant detection with Complete Genomics data.
19/09/2010 - Diether Lambrechts identified – in collaboration with several international teams – susceptibility loci for different gynecological cancers. Their findings resulted in three Nature Genetics papers.